干细胞来源细胞外囊泡经致死性-7微小RNA改善MDR2敲除小鼠的胆管反应
该研究评估肝干细胞来源细胞外囊泡(LSCEVs)对MDR2-/-小鼠胆管反应和胆汁性纤维化的作用,并比较其微小RNA含量与肝细胞来源囊泡的差异。LSCEVs可减少胆管反应和胆汁性纤维化,胆管细胞生长受抑、肝星状细胞失活,其机制与let-7微小RNA抑制NF-κB和IL-13信号通路相关。
要点
- LSCEVs减少MDR2-/-小鼠胆管反应和胆汁性纤维化,抑制胆管细胞生长并失活肝星状细胞。
- LSCEVs中let-7微小RNA较肝细胞来源囊泡大幅增加,MDR2-/-小鼠和原发硬化性胆管炎样本let-7水平降低。
- LSCEVs通过抑制NF-κB和IL-13信号通路降低Lin28a、Lin28b、IL-13、NR1H4和NF-κB水平。
核心结论
- LSCEVs可能成为胆管病的治疗方法,或可用于未来治疗的靶点验证。
研究设计与样本
- 研究评估肝干细胞来源细胞外囊泡(LSCEVs)的内容物,比较其微小RNA与肝细胞来源囊泡的差异,并评估下游靶点。
- 研究评估LSC、胆管细胞和人肝星状细胞(HSCs)之间的交互作用,并在MDR2-/-小鼠中评估LSCEVs的作用。
主要发现
- LSCEVs能够减少MDR2-/-小鼠的胆管反应和胆汁性纤维化。
- LSCEVs处理的MDR2-/-小鼠中胆管细胞生长减少,HSCs失活。
- 与肝细胞来源囊泡相比,LSCEVs中let-7微小RNA大幅增加。
- MDR2-/-小鼠和人类原发硬化性胆管炎样本中let-7水平较对照降低。
- MDR2-/-小鼠肝组织和分离的胆管细胞中let-7下游靶点Lin28a、Lin28b、IL-13、NR1H4和NF-κB升高,LSCEVs处理通过抑制NF-κB和IL-13信号通路降低这些介质水平。
临床怎么用
- 作者认为LSCEVs可能成为胆管病的治疗方法,或可用于未来治疗的靶点验证。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cholangiopathies are diseases that affect cholangiocytes, the cells lining the biliary tract. Liver stem cells (LSCs) are able to differentiate into all cells of the liver and possibly influence the surrounding liver tissue by secretion of signaling molecules. One way in which cells can interact is through secretion of extracellular vesicles (EVs), which are small membrane-bound vesicles that contain proteins, microRNAs (miRNAs), and cytokines. We evaluated the contents of liver stem cell-derived EVs (LSCEVs), compared their miRNA contents to those of EVs isolated from hepatocytes, and evaluated the downstream targets of these miRNAs. We finally evaluated the crosstalk among LSCs, cholangiocytes, and human hepatic stellate cells (HSCs). We showed that LSCEVs were able to reduce ductular reaction and biliary fibrosis in multidrug resistance protein 2 (MDR2)-/- mice. Additionally, we showed that cholangiocyte growth was reduced and HSCs were deactivated in LSCEV-treated mice. Evaluation of LSCEV contents compared with EVs derived from hepatocytes showed a large increase in the miRNA, lethal-7 (let-7). Further evaluation of let-7 in MDR2-/- mice and human primary sclerosing cholangitis samples showed reduced levels of let-7 compared with controls. In liver tissues and isolated cholangiocytes, downstream targets of let-7 (identified by ingenuity pathway analysis), Lin28a (Lin28 homolog A), Lin28b (Lin28 homolog B), IL-13 (interleukin 13), NR1H4 (nuclear receptor subfamily 1 group H member 4) and NF-κB (nuclear factor kappa B), are elevated in MDR2-/- mice, but treatment with LSCEVs reduced levels of these mediators of ductular reaction and biliary fibrosis through the inhibition of NF-κB and IL-13 signaling pathways. Evaluation of crosstalk using cholangiocyte supernatants from LSCEV-treated cells on cultured HSCs showed that HSCs had reduced levels of fibrosis and increased senescence. Conclusion: Our studies indicate that LSCEVs could be a possible treatment for cholangiopathies or could be used for target validation for future therapies.
引用
- McDaniel K, Wu N, Zhou T, et al. Amelioration of Ductular Reaction by Stem Cell Derived Extracellular Vesicles in MDR2 Knockout Mice via Lethal-7 microRNA. Hepatology. 2019. PMID: 30723922. doi:10.1002/hep.30542
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。